Using pulsed dye laser therapy to improve burn scars
The Role of Pulsed Dye Laser Therapy in the Management of Burn Scars
NA · University of Manitoba · NCT01488240
This study is testing whether pulsed dye laser therapy can improve the appearance and feel of burn scars in people with recent burn injuries.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 6 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Sponsor | University of Manitoba (other) |
| Locations | 1 site (Winnipeg, Manitoba) |
| Trial ID | NCT01488240 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effects of pulsed dye laser therapy on burn scars, focusing on factors such as scar height, texture, redness, and pliability in patients with acute burn injuries. The research will involve randomized controlled trials to assess the effectiveness of this laser treatment compared to other modalities. By investigating both acute and late burn scars, the study seeks to provide conclusive evidence regarding the utility of pulsed dye laser therapy in managing burn scars.
Who should consider this trial
Good fit: Ideal candidates are individuals with burn scars aged between one to six months, residing in Winnipeg, and with Fitzpatrick skin types I-III.
Not a fit: Patients with open wounds, active infections, or a history of keloid scarring may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly improve the appearance and quality of life for patients with burn scars.
How similar studies have performed: While there is existing literature supporting laser therapy for burn scars, this study aims to fill the gap of appropriately powered randomized controlled trials, making it a novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * burn scar * living in Winnipeg * scar age one to 6 months * Fitzpatrick I-III skin type Exclusion Criteria: * open wound * active infection * previous scar treatment with steroid injection or interferon * established disposition towards keloid scarring
Where this trial is running
Winnipeg, Manitoba
- University of Manitoba — Winnipeg, Manitoba, Canada (RECRUITING)
Study contacts
- Principal investigator: S Logsetty, MD — University of Manitoba
- Study coordinator: Justin P Gawaziuk, MSc
- Email: jgawaziuk@hsc.mb.ca
- Phone: 2047873669
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Burn Scar, burn, scar, laser